Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administering Convalescent Plasma Rich With Neutralizing Abs. to Hospitalized Adults With WNV - a Double-blind Randomized Controlled Study

NCT06590207 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT06590207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06590207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administering Convalescent Plasma Rich With Neutralizing Abs. to Hospitalized Adults With WNV - a Double-blind Randomized Controlled Study
Lead sponsor
Sheba Medical Center
Phase
Phase 3
Overall status
Completed
Start date
July 4, 2024
Completion date
March 30, 2025
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

west nile fever with neurologic manifestation (diagnosis), west nile fever without complications